JAC Advance Access originally published online on October 4, 2005
Journal of Antimicrobial Chemotherapy 2005 56(5):985-986; doi:10.1093/jac/dki351
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Macrolide, lincosamide and streptogramin B resistance in a dominant clone of Australian community methicillin-resistant Staphylococcus aureus
1 Gram-Positive Bacteria Typing and Research Unit, Curtin University of Technology, School of Biomedical Sciences, Molecular Genetics Research Unit, Perth, Western Australia, Australia; 2 Curtin University of Technology, School of Biomedical Sciences, Molecular Genetics Research Unit, Perth, Western Australia, Australia; 3 Gram-Positive Bacteria Typing and Research Unit, Curtin University of Technology School of Biomedical Sciences and Department of Microbiology and Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia; 4 Gram-Positive Bacteria Typing and Research Unit, Department of Microbiology and Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia
* Corresponding author. Tel: +61-8-92240302; Fax: +61-8-92240303; E-mail: robrienf@alpha8.curtin.edu.au
Keywords: community-acquired infections , resistance genes , plasmids
| The first 10% of the full text of this article appears below. |
Sir,
Community methicillin-resistant Staphylococcus aureus (CMRSA) are becoming important community pathogens and, although most are currently resistant to few antibiotics except the ß-lactams, medical practitioners still have limited therapeutic choices for managing infections in the community. The Gram-positive Bacteria Typing and Research Unit in Western Australia (WA) characterizes
Transparency declarations